Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy

References

• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840–6
   PubMed Web of Science ®Google Scholar
• Zunino S. Type 2 diabetes and glycemic response to grapes or grape products. J Nutr 2009;139:1794S–800S
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Thiagarajan R, Rastrelli L, et al. Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem 2015;15:2445–55
   PubMed Web of Science ®Google Scholar
• Gavin JR III, Alberti K, Davidson MB, DeFronzo RA. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001;24:S5
   PubMed Web of Science ®Google Scholar
• Imperatore G, Boyle JP, Thompson TJ, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012;35:2515–20
   PubMed Web of Science ®Google Scholar
• Van Belle TL, Coppieters KT, Von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011;91:79–118
   PubMed Web of Science ®Google Scholar
• Kahn S. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3–19
   PubMed Web of Science ®Google Scholar
• Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341–5
   PubMed Web of Science ®Google Scholar
• Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249–57
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Habtemariam S, Daglia M, et al. Anthocyanins as a potential therapy for diabetic retinopathy. Curr Med Chem 2015;22:51–8
   PubMed Web of Science ®Google Scholar
• Driskill WT. Diabetes continues to the nation’s fourth leading cause of death. Health Edu 1996;12:18–23
   Google Scholar
• King GL, Kunisaki M, Nishio Y, et al. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 1996;45:S105–S8
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058–70
   PubMed Web of Science ®Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77–82
   Google Scholar
• Curtis T, Gardiner T, Stitt A. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye 2009;23:1496–508
   PubMed Web of Science ®Google Scholar
• Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007;298:902–16
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Yoshida A. Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease. Diabetes Care 2013;36:957–61
   PubMed Web of Science ®Google Scholar
• Izzedine H, Bodaghi B, Launay-Vacher V, Deray G. Eye and kidney: from clinical findings to genetic explanations. J Am Soc Nephrol 2003;14:516–29
   PubMed Web of Science ®Google Scholar
• Russell-Eggitt I, Bockenhauer D. The blind kidney: disorders affecting kidneys and eyes. Pediatr Nephrol 2013;28:2255–65
   PubMed Web of Science ®Google Scholar
• Evans T, Deng DX, Chen S, Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 2000;49:662–6
   PubMed Web of Science ®Google Scholar
• Carlson EC. Scanning and transmission electron microscopic studies of normal and diabetic acellular glomerular and retinal microvessel basement membranes. Microsc Res Tech 1994;28:165–77
   PubMed Web of Science ®Google Scholar
• Goodwin P. Management of diabetic retinopathy: a systematic review. Evid Based Ophthalmol 2008;9:36–7
   Google Scholar
• Gardner TW, Antonetti DA, Barber AJ, et al. Group PSRR. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002;47:S253–S62
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450–2
   PubMed Web of Science ®Google Scholar
• Pfister F, Feng Y, vom Hagen F, et al. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008;57:2495–502
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–64
   PubMed Web of Science ®Google Scholar
• Crawford TN, Alfaro I, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5:8–13
   PubMedGoogle Scholar
• Patel V, Rassam S, Newsom R, et al. Retinal blood flow in diabetic retinopathy. BMJ 1992;305:678–83
   PubMed Web of Science ®Google Scholar
• Ferris FL, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 1984;28:452–61
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603
   PubMedGoogle Scholar
• Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52:1156–63
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 2012;57:347–70
   PubMed Web of Science ®Google Scholar
• Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003;26:1731–7
   PubMed Web of Science ®Google Scholar
• Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care 2004;27:s84–s7
   PubMed Web of Science ®Google Scholar
• Williams GA, Scott IU, Haller JA, et al. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004;111:1055–62
   PubMed Web of Science ®Google Scholar
• Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759–67
   PubMed Web of Science ®Google Scholar
• Abràmoff MD, Niemeijer M, Suttorp-Schulten MS, et al. Evaluation of a system for automatic detection of diabetic retinopathy from color fundus photographs in a large population of patients with diabetes. Diabetes Care 2008;31:193–8
   PubMed Web of Science ®Google Scholar
• Oliver SC, Schwartz SD, editors. Peripheral Vessel Leakage (PVL): A New Angiographic Finding in Diabetic Retinopathy Identified with Ultra Wide-Field Fluorescein Angiography. Seminars in Ophthalmology; 2010: London: Informa UK Ltd
   Google Scholar
• Kollias AN, Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int 2010;107:75–83
   PubMed Web of Science ®Google Scholar
• Helbig H. Surgery for diabetic retinopathy. Ophthalmologica 2006;221:103–11
   Web of Science ®Google Scholar
• Simó R, Hernández C. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 2008;51:1574–80
   PubMed Web of Science ®Google Scholar
• Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina 2007;27:816–24
   PubMed Web of Science ®Google Scholar
• Yorston D, Wickham L, Benson S, et al. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:365–8
   PubMed Web of Science ®Google Scholar
• Simó R, Hernandez C. Advances in the medical treatment of diabetic retinopathy. Diabetes Care 2009;32:1556–62
   PubMed Web of Science ®Google Scholar
• Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res 1984;3:223–7
   PubMed Web of Science ®Google Scholar
• Catala A. Lipid peroxidation of membrane phospholipids in the vertebrate retina. Front Biosci (Schol Ed) 2010;3:52–60
   Google Scholar
• Van Kuijk F, Buck P. Fatty acid composition of the human macula and peripheral retina. Invest Ophthalmol Vis Sci 1992;33:3493–6
   PubMed Web of Science ®Google Scholar
• Ola MS, Nawaz MI, Siddiquei MM, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications 2012;26:56–64
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 2002;288:2579–88
   PubMed Web of Science ®Google Scholar
• King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527–34
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Engerman RL, Kern TS. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Radic Biol Med 1999;26:371–8
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50:1938–42
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci 2008;49:1645–51
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 2003;52:818–23
   PubMed Web of Science ®Google Scholar
• Kanwar M, Chan P-S, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805–11
   PubMed Web of Science ®Google Scholar
• Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension clinical implications and therapeutic possibilities. Diabetes Care 2008;31:S170–S80
   Web of Science ®Google Scholar
• Sedeek M, Montezano AC, Hebert RL, et al. Oxidative stress, Nox isoforms and complications of diabetes-potential targets for novel therapies. J Cardiovasc Transl Res 2012;5:509–18
   PubMed Web of Science ®Google Scholar
• Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 2002;11:1205–23
   PubMed Web of Science ®Google Scholar
• Safi SZ, Qvist R, Kumar S, et al. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. BioMed Res Int 2014;2014:801269
   PubMed Web of Science ®Google Scholar
• Jeganathan SE. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy. Curr Pharm Biotechnol 2011;12:392–5
   PubMed Web of Science ®Google Scholar
• Wilkinson-Berka JL, Rana I, Armani R, Agrotis A. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clin Sci 2013;124:597–615
   PubMed Web of Science ®Google Scholar
• Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:3941–8
   PubMed Web of Science ®Google Scholar
• Xu Z, Wei Y, Gong J, et al. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia 2014;57:204–13
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci 2003;44:5327–34
   PubMed Web of Science ®Google Scholar
• Du Y, Miller CM, Kern T. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003;35:1491–9
   PubMed Web of Science ®Google Scholar
• Cui Y, Xu X, Bi H, et al. Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp Eye Res 2006;83:807–16
   PubMed Web of Science ®Google Scholar
• Ellis EA, Guberski DL, Somogyi-Mann M, Grant MB. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 2000;28:91–101
   PubMed Web of Science ®Google Scholar
• Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann NY Acad Sci 2003;1005:43–54
   PubMed Web of Science ®Google Scholar
• Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346–52
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988;263:17205–8
   PubMed Web of Science ®Google Scholar
• Kowluru R. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetol 2001;38:179–85
   PubMed Web of Science ®Google Scholar
• Kubota S, Kurihara T, Mochimaru H, et al. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and Nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci 2009;50:3512–19
   PubMed Web of Science ®Google Scholar
• Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103
   PubMed Web of Science ®Google Scholar
• Ejaz S, Chekarova I, Ejaz A, et al. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 2008;10:53–63
   PubMed Web of Science ®Google Scholar
• Yatoh S, Mizutani M, Yokoo T, et al. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev 2006;22:38–45
   PubMed Web of Science ®Google Scholar
• Mancino R, Di Pierro D, Varesi C, et al. Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis 2011;17:1298–304
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Nabavi SM, N Setzer W, et al. Antioxidant and antihemolytic activity of lipid-soluble bioactive substances in avocado fruits. Fruits 2013;68:185–93
   Web of Science ®Google Scholar
• Nabavi SF, Nabavi SM, Ebrahimzadeh MA, et al. In vitro antioxidant and antihemolytic activities of hydroalcoholic extracts of Allium scabriscapum Boiss. & Ky. aerial parts and bulbs. Int J Food Prop 2013;16:713–22
   Web of Science ®Google Scholar
• Alinezhad H, Azimi R, Zare M, et al. Antioxidant and antihemolytic activities of ethanolic extract of flowers, leaves, and stems of Hyssopus officinalis L. Var. angustifolius. Int J Food Prop 2013;16:1169–78
   Web of Science ®Google Scholar
• Nabavi SF, Nabavi SM, Habtemariam S, et al. Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress. Ind Crops Prod 2013;44:50–5
   Web of Science ®Google Scholar
• Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 2009;47:333–43
   PubMed Web of Science ®Google Scholar
• Davis W, Ronai Z, Tew KD. Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 2001;296:1–6
   PubMed Web of Science ®Google Scholar
• Meyer JN, Leung MC, Rooney JP, et al. Mitochondria as a target of environmental toxicants. Toxicol Sci 2013;134:1–17
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals and antioxidants – quo vadis? Trends Pharmacol Sci 2011;32:125–30
   PubMed Web of Science ®Google Scholar
• Li H, Horke S, Förstermann U. Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 2013;34:313–19
   PubMed Web of Science ®Google Scholar
• Matés JM, Segura JA, Alonso FJ, Márquez J. Oxidative stress in apoptosis and cancer: an update. Arch Toxicol 2012;86:1649–65
   PubMed Web of Science ®Google Scholar
• Federico A, Cardaioli E, Da Pozzo P, et al. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012;322:254–62
   PubMed Web of Science ®Google Scholar
• Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011;50:567–75
   PubMed Web of Science ®Google Scholar
• Surh Y-J, Kundu JK, Na H-K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008;74:1526–39
   PubMed Web of Science ®Google Scholar
• Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549–57
   PubMed Web of Science ®Google Scholar
• Calkins MJ, Johnson DA, Townsend JA, et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 2009;11:497–508
   PubMed Web of Science ®Google Scholar
• Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophysic Res Commun 1997;236:313–22
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang M-I, Okawa H, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004;24:7130–9
   PubMed Web of Science ®Google Scholar
• Ma Q, He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 2012;64:1055–81
   PubMed Web of Science ®Google Scholar
• de Vries HE, Witte M, Hondius D, et al. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 2008;45:1375–83
   PubMed Web of Science ®Google Scholar
• Itoh K, Mochizuki M, Ishii Y, et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol Cell Biol 2004;24:36–45
   PubMed Web of Science ®Google Scholar
• Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003;23:8137–51
   PubMed Web of Science ®Google Scholar
• Huang H-C, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002;277:42769–74
   PubMed Web of Science ®Google Scholar
• Clements CM, McNally RS, Conti BJ, et al. DJ-1, a cancer-and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 2006;103:15091–6
   PubMed Web of Science ®Google Scholar
• Bitar MS, Liu C, Ziaei A, et al. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2012;53:5806–13
   PubMed Web of Science ®Google Scholar
• Liu C, Chen Y, Kochevar IE, Jurkunas UV. Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells. Invest Ophthalmol Vis Sci 2014;55:5551–60
   PubMed Web of Science ®Google Scholar
• Eggler AL, Gay KA, Mesecar AD. Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 2008;52:S84–94
   PubMed Web of Science ®Google Scholar
• Jeong W-S, Jun M, Kong A-NT. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006;8:99–106
   PubMed Web of Science ®Google Scholar
• Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005;224:171–84
   PubMed Web of Science ®Google Scholar
• Johnson F, Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005;26:340–52
   PubMedGoogle Scholar
• Lloyd RV, Hanna PM, Mason RP. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic Biol Med 1997;22:885–8
   PubMed Web of Science ®Google Scholar
• Wood ZA, Poole LB, Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 2003;300:650–3
   PubMed Web of Science ®Google Scholar
• Gaetani GF, Galiano S, Canepa L, et al. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989;73:334–9
   PubMed Web of Science ®Google Scholar
• Trujillo M, Ferrer-Sueta G, Thomson L, et al. Kinetics of Peroxiredoxins and Their Role in the Decomposition of Peroxynitrite. Springer: Peroxiredoxin Systems; 2007:83–113
   Google Scholar
• Sassa S. Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxid Redox Signal 2004;6:819–24
   PubMed Web of Science ®Google Scholar
• Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010;50:323–54
   PubMed Web of Science ®Google Scholar
• Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:1238–47
   PubMed Web of Science ®Google Scholar
• Raina AK, Templeton DJ, Deak JC, et al. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer’s disease. Redox Rep 1999;4:23–7
   PubMed Web of Science ®Google Scholar
• Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997;2:155–76
   Google Scholar
• Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000;267:4904–11
   PubMedGoogle Scholar
• Hayes JD, Mclellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273–300
   PubMed Web of Science ®Google Scholar
• Kowluru R, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res 1994;13:891–6
   PubMed Web of Science ®Google Scholar
• Cotter MA, Love A, Watt MJ, et al. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 1995;38:1285–94
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kern TS, Engerman RL, Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 1996;45:1233–7
   PubMed Web of Science ®Google Scholar
• Maher P, Hanneken A. Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest Ophthalmol Vis Sci 2005;46:4796–803
   PubMed Web of Science ®Google Scholar
• Nagai N, Thimmulappa RK, Cano M, et al. Nrf2 is a critical modulator of the innate immune response in a model of uveitis. Free Radic Biol Med 2009;47:300–6
   PubMed Web of Science ®Google Scholar
• Wei Y, Gong J, Yoshida T, et al. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radic Biol Med 2011;51:216–24
   PubMed Web of Science ®Google Scholar
• Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783–91
   PubMed Web of Science ®Google Scholar
• Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:283–90
   PubMed Web of Science ®Google Scholar
• Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008;586:4401–8
   PubMed Web of Science ®Google Scholar
• Gastinger MJ, Singh RS, Barber AJ. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and ins2akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 2006;47:3143–50
   PubMed Web of Science ®Google Scholar
• Shanab AY, Nakazawa T, Ryu M, et al. Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor. Neurobiol Dis 2012;48:556–67
   PubMed Web of Science ®Google Scholar
• Fan J, Xu G, Jiang T, Qin Y. Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats. Invest Ophthalmol Vis Sci 2012;53:6541–56
   PubMed Web of Science ®Google Scholar
• Mishra M, Zhong Q, Kowluru RA. Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55:7256–65
   PubMed Web of Science ®Google Scholar
• Mishra M, Zhong Q, Kowluru RA. Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. Free Radic Biol Med 2014;75:129–39
   PubMed Web of Science ®Google Scholar
• Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005;46:2210–18
   PubMed Web of Science ®Google Scholar
• Lee CA, Li G, Patel MD, et al. Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Invest Ophthalmol Vis Sci 2014;55:2904–10
   PubMed Web of Science ®Google Scholar
• Aung MH, Park HN, Han MK, et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci 2014;34:726–36
   PubMed Web of Science ®Google Scholar
• Aung MH, Kim MK, Olson DE, et al. Early visual deficits in streptozotocin-induced diabetic long Evans rats. Invest Ophthalmol Vis Sci 2013;54:1370–7
   PubMed Web of Science ®Google Scholar
• Akimov NP, Renteria RC. Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2Akita mouse model of diabetes. Behav Brain Res 2012;226:601–5
   PubMed Web of Science ®Google Scholar
• Xu X, Luo P, Wang Y, et al. Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications. J Int Med Res 2013;41:13–19
   PubMed Web of Science ®Google Scholar
• Del Rio D, Rodriguez-Mateos A, Spencer JP, et al. Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013;18:1818–92
   PubMed Web of Science ®Google Scholar
• Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr 2013;4:384S–92S
   PubMed Web of Science ®Google Scholar
• Manach C, Scalbert A, Morand C, et al. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727–47
   PubMed Web of Science ®Google Scholar
• Turpaev KT. Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles. Biochemistry 2013;78:111–26
   PubMed Web of Science ®Google Scholar
• Zenkov NK, Menshchikova EB, Tkachev VO. Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target. Biochemistry 2013;78:19–36
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Daglia M, Moghaddam AH, et al. Curcumin and liver disease: from chemistry to medicine. Compre Rev Food Sci Food Safe 2014;13:62–77
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Talalay P. Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 1999;20:911–14
   PubMed Web of Science ®Google Scholar
• Magesh S, Chen Y, Hu L. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 2012;32:687–726
   PubMed Web of Science ®Google Scholar
• Zhang X, Liang D, Guo L, et al. Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. Mol Med Rep 2015;12:1347–55
   PubMed Web of Science ®Google Scholar
• González-Reyes S, Guzmán-Beltrán S, Medina-Campos ON, Pedraza-Chaverri J. Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxid Med Cell Longev 2013;2013:801418
   PubMed Web of Science ®Google Scholar
• Zhao R, Yang B, Wang L, et al. Curcumin protects human keratinocytes against inorganic arsenite-induced acute cytotoxicity through an NRF2-dependent mechanism. Oxid Med Cell Longev 2013;2013:412576
   PubMedGoogle Scholar
• Zhao SG, Li Q, Liu ZX, et al. Curcumin attenuates insulin resistance in hepatocytes by inducing Nrf2 nuclear translocation. Hepatogastroenterology 2011;58:2106–11
   PubMed Web of Science ®Google Scholar
• Kang ES, Woo IS, Kim HJ, et al. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic Biol Med 2007;43:535–45
   PubMed Web of Science ®Google Scholar
• Boyanapalli SS, Paredes-Gonzalez X, Fuentes F, et al. Nrf2 knockout attenuates the anti-inflammatory effects of phenethyl isothiocyanate and curcumin. Chem Res Toxicol 2014;27:2036–43
   PubMed Web of Science ®Google Scholar
• Zeng C, Zhong P, Zhao Y, et al. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. J Mol Cell Cardiol 2015;79:1–12
   PubMed Web of Science ®Google Scholar
• Li B, Wang L, Lu Q, Da W. Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect? Ir J Med Sci 2014; doi:10.1007/s11845-014-1226-9
   Google Scholar
• Farombi EO, Shrotriya S, Na HK, et al. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 2008;46:1279–87
   PubMed Web of Science ®Google Scholar
• Wu J, Li Q, Wang X, et al. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 2013;8:e59843
   PubMed Web of Science ®Google Scholar
• Yang C, Zhang X, Fan H, Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133–41
   PubMed Web of Science ®Google Scholar
• Carmona-Ramírez I, Santamaría A, Tobón-Velasco JC, et al. Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity. J Nutr Biochem 2013;24:14–24
   PubMed Web of Science ®Google Scholar
• Soetikno V, Sari FR, Lakshmanan AP, et al. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res 2013;57:1649–59
   PubMed Web of Science ®Google Scholar
• Tapia E, Soto V, Ortiz-Vega KM, et al. Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid Med Cell Longev 2012;2012:269039
   PubMed Web of Science ®Google Scholar
• Yang H, Xu W, Zhou Z, et al. Curcumin attenuates urinary excretion of albumin in type ii diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (nrf2) system and repressing inflammatory signaling efficacies. Exp Clin Endocrinol Diabetes 2015;123:360–7
   PubMed Web of Science ®Google Scholar
• Wu RP, Hayashi T, Cottam HB, et al. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2010;107:7479–84
   PubMed Web of Science ®Google Scholar
• Rubiolo JA, Vega FV. Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species. Biomed Pharmacother 2008;62:606–12
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 2010;299:H18–24
   PubMed Web of Science ®Google Scholar
• Wagner AE, Boesch-Saadatmandi C, Breckwoldt D, et al. Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2. BMC Complement Altern Med 2011;11:1
   PubMed Web of Science ®Google Scholar
• Cheng AS, Cheng YH, Chiou CH, Chang TL. Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J Agric Food Chem 2012;60:9180–7
   PubMed Web of Science ®Google Scholar
• Javkhedkar AA, Quiroz Y, Rodoriguez-Iturbe B, et al. Resveratrol restored Nrf2 function, reduced renal inflammation and mitigated hypertension in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2015;308:R840–6
   PubMed Web of Science ®Google Scholar
• Palsamy P, Subramanian S. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 2011;1812:719–31
   PubMed Web of Science ®Google Scholar
• Hao E, Lang F, Chen Y, et al. Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor. PLoS One 2013;8:e69452
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh CK, Lavoie HA, et al. Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders. Mol Pharmacol 2011;80:446–57
   PubMed Web of Science ®Google Scholar
• Ren J, Fan C, Chen N, et al. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 2011;36:2352–62
   PubMed Web of Science ®Google Scholar
• Singh B, Shoulson R, Chatterjee A, et al. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis 2014;35:1872–80
   PubMed Web of Science ®Google Scholar
• Nabavi SM, Nabavi SF, Eslami S, Moghaddam AH. In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem 2012;132:931–5
   Web of Science ®Google Scholar
• Nabavi SF, Russo GL, Daglia M, Nabavi SM. Role of quercetin as an alternative for obesity treatment: you are what you eat! Food Chem 2015;179:305–10
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Nabavi SM, Mirzaei M, Moghaddam AH. Protective effect of quercetin against sodium fluoride induced oxidative stress in rat’s heart. Food Funct 2012;3:437–41
   PubMed Web of Science ®Google Scholar
• Russo M, Spagnuolo C, Tedesco I, et al. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012;83:6–15
   PubMed Web of Science ®Google Scholar
• Russo GL, Russo M, Spagnuolo C, et al. Quercetin: a pleiotropic kinase inhibitor against cancer. Cancer Treat Res 2014;159:185–205
   PubMedGoogle Scholar
• Weng CJ, Chen MJ, Yeh CT, Yen GC. Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity. N Biotechnol 2011;28:767–77
   PubMed Web of Science ®Google Scholar
• Granado-Serrano AB, Martín MA, Bravo L, et al. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact 2012;195:154–64
   PubMed Web of Science ®Google Scholar
• Tanigawa S, Fujii M, Hou DX. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 2007;42:1690–703
   PubMed Web of Science ®Google Scholar
• Saw CL, Guo Y, Yang AY, et al. The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food Chem Toxicol 2014;72:303–11
   PubMed Web of Science ®Google Scholar
• Yao P, Nussler A, Liu L, et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 2007;47:253–61
   PubMed Web of Science ®Google Scholar
• Ramyaa P, Krishnaswamy R, Padma VV. Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells – upregulation of Nrf2 expression and down regulation of NF-κB and COX-2. Biochim Biophys Acta 2014;1840:681–92
   PubMed Web of Science ®Google Scholar
• Ramyaa P, Padma VV. Ochratoxin-induced toxicity, oxidative stress and apoptosis ameliorated by quercetin-modulation by Nrf2. Food Chem Toxicol 2013;62:205–16
   PubMed Web of Science ®Google Scholar
• Ji LL, Sheng YC, Zheng ZY, et al. The Involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity. Free Radic Biol Med 2015;85:12–23
   PubMed Web of Science ®Google Scholar
• Kimura S, Warabi E, Yanagawa T, et al. Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem Biophys Res Commun 2009;387:109–14
   PubMed Web of Science ®Google Scholar
• Miyamoto N, Izumi H, Miyamoto R, et al. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest Ophthalmol Vis Sci 2011;52:1055–63
   PubMed Web of Science ®Google Scholar
• Kang CH, Choi YH, Moon SK, et al. Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-dependent HO-1 pathway. Int Immunopharmacol 2013;17:808–13
   PubMed Web of Science ®Google Scholar
• Arredondo F, Echeverry C, Abin-Carriquiry JA, et al. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med 2010;49:738–47
   PubMed Web of Science ®Google Scholar
• Renaud J, Nabavi SM, Daglia M, et al. Epigallocatechin-3-gallate, a promising molecule for Parkinson’s disease? Rejuvenation Res 2015;18:257–69
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 2011;64:105–12
   PubMed Web of Science ®Google Scholar
• Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 2000;23:605–12
   PubMed Web of Science ®Google Scholar
• Wu CC, Hsu MC, Hsieh CW, et al. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006;78:2889–97
   PubMed Web of Science ®Google Scholar
• Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 2008;46:1271–8
   PubMed Web of Science ®Google Scholar
• Jiang J, Mo ZC, Yin K, et al. Epigallocatechin-3-gallate prevents TNF-α-induced NF-κB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells. Int J Mol Med 2012;29:946–56
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu N, Su X, et al. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Biomed Pharmacother 2015;70:260–7
   PubMed Web of Science ®Google Scholar
• Zhang HS, Wu TC, Sang WW, Ruan Z. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway. Life Sci 2012;90:747–54
   PubMed Web of Science ®Google Scholar
• Han SG, Han SS, Toborek M, Hennig B. EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes. Toxicol Appl Pharmacol 2012;261:181–8
   PubMed Web of Science ®Google Scholar
• Zhang ZM, Yang XY, Yuan JH, et al. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Chin Med J 2009;122:1660–5
   PubMed Web of Science ®Google Scholar
• Nair S, Barve A, Khor TO, et al. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacol Sin 2010;31:1223–40
   PubMed Web of Science ®Google Scholar
• Tsai PY, Ka SM, Chang JM, et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med 2011;51:744–54
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang B, Du F, et al. Epigallocatechin-3-gallate attenuates oxidative stress and inflammation in obstructive nephropathy via NF-κB and Nrf2/HO-1 signalling pathway regulation. Basic Clin Pharmacol Toxicol 2015;117:164–72
   PubMed Web of Science ®Google Scholar
• Ye T, Zhen J, Du Y, et al. Green tea polyphenol (-)-epigallocatechin-3-gallate restores nrf2 activity and ameliorates crescentic glomerulonephritis. PLoS One 2015;10:e0119543
   PubMed Web of Science ®Google Scholar
• Sahin K, Tuzcu M, Gencoglu H, et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 2010;87:240–5
   PubMed Web of Science ®Google Scholar
• Sriram N, Kalayarasan S, Sudhandiran G. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther 2009;22:221–36
   PubMed Web of Science ®Google Scholar
• Shen G, Xu C, Hu R, et al. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (−/−) mice. Pharm Res 2005;22:1805–20
   PubMed Web of Science ®Google Scholar
• Wang D, Wang Y, Wan X, et al. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicol Appl Pharmacol 2015;283:65–74
   PubMed Web of Science ®Google Scholar
• Erk T, Hauser J, Williamson G, et al. Structure- and dose-absorption relationships of coffee polyphenols. Biofactors 2014;40:103–12
   PubMed Web of Science ®Google Scholar
• Sirota R, Gibson D, Kohen R. The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines. Redox Biol 2015;4:48–59
   PubMed Web of Science ®Google Scholar
• Chao X, He X, Yang Y, et al. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer’s disease. Bioorg Med Chem Lett 2012;22:6498–502
   PubMed Web of Science ®Google Scholar
• Chao XJ, Chen ZW, Liu AM, et al. Effect of tacrine-3-caffeic acid, a novel multifunctional anti-Alzheimer’s dimer, against oxidative-stress-induced cell death in HT22 hippocampal neurons: involvement of Nrf2/HO-1 pathway. CNS Neurosci Ther 2014;20:840–50
   PubMed Web of Science ®Google Scholar
• Tolba MF, Azab SS, Khalifa AE, et al. Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects. IUBMB Life 2013;65:699–709
   PubMed Web of Science ®Google Scholar
• Kim JK, Jang HD. Nrf2-mediated HO-1 induction coupled with the ERK signaling pathway contributes to indirect antioxidant capacity of caffeic acid phenethyl ester in HepG2 cells. Int J Mol Sci 2014;15:12149–65
   PubMed Web of Science ®Google Scholar
• Lee Y, Shin DH, Kim JH, et al. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur J Pharmacol 2010;643:21–8
   PubMed Web of Science ®Google Scholar
• Kim H, Kim W, Yum S, et al. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation. Free Radic Biol Med 2013;65:552–62
   PubMed Web of Science ®Google Scholar
• Hu T, He XW, Jiang JG, Xu XL. Hydroxytyrosol and its potential therapeutic effects. J Agric Food Chem 2014;62:1449–55
   PubMed Web of Science ®Google Scholar
• Martín MA, Ramos S, Granado-Serrano AB, et al. Hydroxytyrosol induces antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular regulated kinases and phosphatidylinositol-3-kinase/protein kinase B pathways in HepG2 cells. Mol Nutr Food Res 2010;54:956–66
   PubMed Web of Science ®Google Scholar
• Zrelli H, Matsuoka M, Kitazaki S, et al. Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem 2011;59:4473–82
   PubMed Web of Science ®Google Scholar
• Zrelli H, Kusunoki M, Miyazaki H. Role of hydroxytyrosol-dependent regulation of HO-1 expression in promoting wound healing of vascular endothelial cells via Nrf2 de novo synthesis and stabilization. Phytother Res 2015;29:1011–18
   PubMed Web of Science ®Google Scholar
• Schaffer S, Halliwell B. Comment on hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem 2011;59:10770–1
   PubMed Web of Science ®Google Scholar
• Zou X, Feng Z, Li Y, et al. Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways. J Nutr Biochem 2012;23:994–1006
   PubMed Web of Science ®Google Scholar
• Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 2010;1:189–210
   PubMed Web of Science ®Google Scholar
• Ben-Dor A, Steiner M, Gheber L, et al. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005;4:177–86
   PubMed Web of Science ®Google Scholar
• Goo YA, Li Z, Pajkovic N, et al. Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteomics Clin Appl 2007;1:513–23
   PubMed Web of Science ®Google Scholar
• Lian F, Wang XD. Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int J Cancer 2008;123:1262–8
   PubMed Web of Science ®Google Scholar
• Sahin K, Orhan C, Tuzcu M, et al. Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways. Nutr Cancer 2014;66:590–8
   PubMed Web of Science ®Google Scholar
• Dai C, Tang S, Deng S, et al. Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway. Antimicrob Agents Chemother 2015;59:579–85
   PubMed Web of Science ®Google Scholar
• Sahin K, Tuzcu M, Sahin N, et al. Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 2010;48:2670–4
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Zafar SF, El-Rayes BF. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev 2013;71:562–72
   PubMed Web of Science ®Google Scholar
• Zhai X, Lin M, Zhang F, et al. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells. Mol Nutr Food Res 2013;57:249–59
   PubMed Web of Science ®Google Scholar
• Wang R, Tu J, Zhang Q, et al. Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signaling. Hippocampus 2013;23:634–47
   PubMed Web of Science ®Google Scholar
• Lipińska L, Klewicka E, Sójka M. The structure, occurrence and biological activity of ellagitannins: a general review. Acta Sci Pol Technol Aliment 2014;13:289–99
   PubMedGoogle Scholar
• Ding Y, Zhang B, Zhou K, et al. Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation. Int J Cardiol 2014;175:508–14
   PubMed Web of Science ®Google Scholar
• Mrudula T, Suryanarayana P, Srinivas P, Reddy GB. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun 2007;361:528–32
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 2007;4:8
   Google Scholar
• Gupta SK, Kumar B, Nag TC, et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 2011;27:123–30
   PubMed Web of Science ®Google Scholar
• Steigerwalt R, Nebbioso M, Appendino G, et al. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med 2012;54:11
   PubMed Web of Science ®Google Scholar
• Zuo ZF, Zhang Q, Liu XZ. Protective effects of curcumin on retinal Müller cell in early diabetic rats. Int J Ophthalmol 2013;6:422
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee BJ, Kim JH, et al. Anti-angiogenic effect of caffeic acid on retinal neovascularization. Vascul Pharmacol 2009;51:262–7
   PubMed Web of Science ®Google Scholar
• Skopinski P, Szaflik J, Duda-Król B, et al. Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. Int J Mol Med 2004;14:707–18
   PubMed Web of Science ®Google Scholar
• Silva KC, Rosales MA, Hamassaki DE, et al. Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:1325–36
   PubMed Web of Science ®Google Scholar
• Kim H, Choi JS, Kim KS, et al. Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization. Acta Biomater 2012;8:3932–40
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, El-Shishtawy MM, Peña A Jr, Liou GI. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010;16:2033
   PubMed Web of Science ®Google Scholar
• Oh HY, Kim SS, Chung H-Y, Yoon S. Isoflavone supplements exert hormonal and antioxidant effects in postmenopausal Korean women with diabetic retinopathy. J Med Food 2005;8:1–7
   PubMed Web of Science ®Google Scholar
• Nakajima M, Cooney MJ, Tu AH, et al. Normalization of retinal vascular permeability in experimental diabetes with genistein. Invest Ophthalmol Vis Sci 2001;42:2110–14
   PubMed Web of Science ®Google Scholar
• Ghadiri Soufi F, Arbabi‐Aval E, Rezaei Kanavi M, et al. Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats. Clin Exp Pharmacol Physiol 2015;42:63–8
   PubMed Web of Science ®Google Scholar
• Chan C-M, Chang H-H, Wang V-C, et al. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways. PLoS One 2013;8:e56819
   PubMed Web of Science ®Google Scholar
• Yar AS, Menevse S, Dogan I, et al. Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment. J Med Food 2012;15:391–8
   PubMed Web of Science ®Google Scholar
• Liu XQ, Wu BJ, Pan WH, et al. Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. J Ocul Pharmacol Ther 2013;29:33–40
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim YS, Roh GS, et al. Resveratrol blocks diabetes‐induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmol 2012;90:e31–e7
   PubMed Web of Science ®Google Scholar
• Losso JN, Truax RE, Richard G. Trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J Agric Food Chem 2010;58:8246–52
   PubMed Web of Science ®Google Scholar
• Kumar B, Gupta SK, Nag TC, et al. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp Eye Res 2014;125:193–202
   PubMed Web of Science ®Google Scholar
• Lee HS, Jun JH, Jung EH, et al. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Molecules 2014;19:12150–72
   PubMed Web of Science ®Google Scholar